| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
12,116
|
12,967
|
12,006
|
13,592
| | Cost of Revenue | 1,575 | 1,025 | 1,046 | 1,011 | | |
Gross Profit
|
10,541
|
11,942
|
10,960
|
12,581
| |
|
Operating Expenses |
|
Research Development | 5,039 | 4,695 | 4,637 | 5,425 |
|
Selling General and Administrative | 4,193 | 4,829 | 4,175 | 3,953 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,309
|
2,418
|
2,148
|
3,203
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 729 | 727 | 731 | 974 |
|
Earnings Before Interest And Taxes | 2,038 | 3,145 | 2,879 | 4,177 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 2,038 | 3,145 | 2,879 | 4,177 |
|
Income Tax Expense | 333 | 390 | 285 | 698 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,705 | 2,755 | 2,594 | 3,479 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,705
|
2,755
|
2,594
|
3,479
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,705
|
2,755
|
2,594
|
3,479
|
|
0.16(0.86%) 11:03AM EDT - Nasdaq Real Time Price